PHILADELPHIA, April 20 /PRNewswire/ -- The Strategic Research Institute, LLC announced today that plans for this year’s Targeting Ubiquitin for Drug Discovery and Development conference are complete. The meeting, scheduled for June 26-27th in Philadelphia, has gathered together world experts in Ubiquitin science. Industry and academic leaders will present the state-of-the-art and prospects for exploiting this rapidly moving field.
Some of the featured talks include: -- The Velcade(TM) Success Story-The mechanism of action and Clinical Implications -- New insights into the functioning of the proteasome in protein degradation and antigen presentation -- Understanding the complexities of protein ubiquitylation Presenting companies and institutions include:
Celgene, Cognia Corporation, Emory University, Genentech, Genomics Institute of Novartis, Harvard University, Hybrigenics, LSU Health Sciences Center, Millennium, Nereus Pharmaceuticals, Princeton University, Progenra, Proteolix, Proteologics, Rigel Pharmaceuticals and UT Southwestern Medical Center.
To receive the full agenda in PDF, please contact Seth Fritts of Strategic Research Institute at sfritts@srinstitute.com or 212-967-0095, x256. You can also view the agenda and speakers on the web at: http://www.srinstitute.com/cs376 .
Leverage our strong position in the pharmaceutical sector to showcase your products and services to this high-level, targeted audience of pharmaceutical scientists and executive decision makers. To inquire about sponsorship & exhibition opportunities, please contact Seth Fritts at 212-967-0095 x256 or sfritts@srinstitute.com.
To become a media partner, please contact Cheryl Kahan-Radhuber at 212-967-0095 x273 or ckahan-radhuber@srinstitute.com.
Strategic Research Institute
CONTACT: Seth Fritts, +1-212-967-0095 x256, sfritts@srinstitute.com;Cheryl Kahan-Radhuber, +1-212-967-0095 x273,ckahan-radhuber@srinstitute.com, both Strategic Research Institute
